Founded in 2007, Patsnap is the global leader in AI-powered R&D, competitive intelligence, and IP insights, delivering better answers that facilitate faster and more confident decision-making. Synapse by Patsnap is the premier AI-driven, end-to-end commercial intelligence platform specifically designed for the biopharma sector. Leveraging interconnected datasets that encompass R&D, clinical trials, deals, and patents, along with the pharma-trained, trusted AI assistant HiroLS, Synapse empowers users to: - Unlock real-time competitive insights on portfolio strategy and investment opportunities through deals and clinical updates for emerging therapeutic targets. - Conduct comprehensive market landscaping by analyzing market trends, competitor pipelines, and epidemiology data. - Accelerate clinical research by benchmarking against the latest clinical updates across novel modalities and therapeutic indications. - Identify strategic long-term collaborators and partners to commercialize your candidates and maximize opportunities. Key Features: Synapse is the industry-leading SaaS solution tailored for Competitive Intelligence, R&D, and Clinical teams within the pharmaceutical industry, offering key functionalities such as: With integrated datasets, an advanced large language model, named entity recognition, and AI-driven extraction technologies from patent sources, Synapse streamlines data capture and workflow integration: - HiroLS AI Assistant provides generative insights and intelligence - Real-time monitoring of translational, clinical updates, licensing, and deals - Personalized dashboards with customizable visualizations and charts for in-depth analysis - A collaborative cloud-based workspace to break down silos Enhance your R&D and elevate your competitive intelligence with Synapse, driving informed decision-making throughout the drug innovation cycle.